Clinicopathological analysis of primary epithelial appendiceal neoplasms

Medical Oncology

Volumn 27, Issue 4, 2010, Pages 1073-1078

  Gupta, Sachin ^a   Parsa, Venkata ^a   Adsay, Volkan ^b   Heilbrun, Lance K ^a   Smith, Daryn ^a   Shields, Anthony F ^a   Weaver, Donald ^c   Philip, Philip A ^a   El Rayes, Bassel F ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Appendiceal carcinoma; Disseminated peritoneal adenomucinosis (DPAM); Peritoneal mucinous carcinomatosis (PMCA); Pseudomyxoma peritonei

Indexed keywords

ADULT; APPENDIX CARCINOMA; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; APPENDICEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 79951774368     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9337-2     Document Type: Article

References (24)

1. Fann JI, et al. Pseudomyxoma peritonei. Surg Gynecol Obstet. 1993;177(5):441-7. (Pubitemid 23323770)
2. Nitecki SS, et al. The natural history of surgically treated primary adenocarcinoma of the appendix. Ann Surg. 1994;219(1):51-7. (Pubitemid 24032237)
3. Collins DC. 71, 000 Human appendix specimens. A final report, summarizing forty years' study. Am J Proctol. 1963;14:265-81.
4. Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7, 970 appendectomies. Dis Colon Rectum. 1998;41(1):75-80. (Pubitemid 28044879)
5. Kabbani W, et al. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations. Mod Pathol. 2002;15(6):599-605. (Pubitemid 34666462)
6. Muller D. Appendiceal neoplasm resulting from a malignant transformation of a villous adenoma. Chirurg. 1980;51(9):609-10.
7. Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features diagnostic problems, and proposed classification. Adv Anat Pathol. 2005;12(6):291-311. (Pubitemid 44357148)
8. Sugarbaker PH. Are there curative options to peritoneal carcinomatosis? Ann Surg. 2005;242(5):748-50. (author reply 750-1).
9. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxomaperitoneisyndrome? Lancet Oncol. 2006;7(1):69-76. (Pubitemid 43025395)
10. Gonzalez-Moreno S, Brun E, Sugarbaker PH. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2005;12(1):72-80. (Pubitemid 40486644)
11. Gonzalez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91(3):304-11. (Pubitemid 38375769)
12. Bradley RF, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30(5):551-9. (Pubitemid 44265007)
13. Misdraji J, et al. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003;27(8):1089-103. (Pubitemid 36909530)
14. Ronnett BM, et al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92(1):85-91. (Pubitemid 32623044)
15. Stewart JH, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13(5):624-34.
16. Yan H, et al. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol. 2001;14(3):164-71. (Pubitemid 32246819)
17. Ronnett BM, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995;19(12):1390-408.
18. Lee ET, Wang JW. Statistical methods for survival data analysis. 3rd ed. Wiley: Hoboken; 2003. p. 76-91.
19. Pai RK, Longacre TA. Pseudomyxoma peritonei syndrome: classification of appendiceal mucinous tumours. Cancer Treat Res. 2007;134:71-107.
20. Ito H, et al. Appendiceal adenocarcinoma: long-term outcomes after surgical therapy. Dis Colon Rectum. 2004;47(4):474-80. (Pubitemid 38436653)
21. Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg. 2000;87(10):1414-8.
22. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6(8):727-31. (Pubitemid 30013648)
23. Sugarbaker PH, et al. Pseudomyxoma peritonei. Br J Surg. 1999;86(6):842.
24. Sugarbaker PH. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer. Cancer Invest. 2005;23(2):155-72. (Pubitemid 40463914)